Metformin C4 Health

Metformin, the active ingredient in Metformin C4 Health, is a biguanide presented as an unknown/unknown for oral use. It treats type 2 diabetes mellitus in adults by improving blood glucose control.

GNH USA supplies Metformin C4 Health as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin is indicated for disorders of glucose metabolism and related conditions.

Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels. Prediabetes (impaired glucose tolerance): helps delay progression to overt diabetes. Polycystic ovary syndrome (off‑label): may improve insulin resistance and menstrual regularity.

Metformin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite. - Diarrhea: frequent loose stools, especially during dose titration. - Metallic taste: transient alteration of taste perception. - Vitamin B12 reduction: mild decrease with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatotoxicity: abnormal liver enzymes indicating liver injury.

Metformin should be used with caution in specific clinical situations. - Renal function: assess eGFR before initiation and periodically thereafter. - Hepatic function: monitor liver enzymes in patients with liver disease. - Lactic acidosis risk: avoid in patients with hypoxia, heart failure, or severe infection. - Vitamin B12 monitoring: consider periodic testing during long‑term therapy. - Pregnancy and lactation: discuss potential risks with a healthcare professional. - Store at ambient temperature: keep below 25°C, protect from moisture, and retain in the original packaging.

Metformin may interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Alcohol: increases risk of lactic acidosis. - Iodinated contrast agents: can precipitate acute renal failure. - Cimetidine: may raise plasma metformin concentrations.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors/ARBs: monitor renal function and electrolytes.